In today’s episode, I interview Dr. Kim Capone the Chief Scientific Officer of Femtec Health. FemTec Health intends to integrate genetic, microbiome, and biometric data into a consumer-driven digital health experience with a focus on women’s specific health issues. This is a special episode because Femtec Health has just emerged from stealth mode and requested to tell their story on our show. Normally I like to interview people and companies that have been around and made huge strides to advance women’s health. This company is interesting because prior to their press release they raised $38M from big-name investors including Longmont Capital, Ithaca LifeSciences, Unilever Ventures, Shiseido, E Ventures, Viking Global, and Trinity Capital. They acquired Birchbox makeup subscription service, Mira Beauty, and Liquid Grids a healthcare marketing platform. At launch, the company has over 10M members, 2 clinical trials in progress, and a team of 150 people around the world. The founder Dr. Kimon Angelides has previously exited four healthcare companies with billions in exit value. Femtec Health claims to bring together products, services, and data analytics to accommodate continued care for women at every stage of their life. Their patent-pending BiomeAI engine uses AI and deep machine learning to translate consumer, genetic, microbiome, and biometric data into holistic personalized healthcare for women. One cannot deny the splash Femtec Health has created. Enjoy the episode!